USD 4.4 billion
Peptic Ulcer Drugs Market Size, Share, Growth Analysis, By Type(Proton pump inhibitors (PPIs), histamine H2-receptor antagonists, antacids, and antibiotics), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35G2166 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
37
|Figures:
74
Peptic Ulcer Drugs Market Insights
Peptic Ulcer Drugs Market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 4.76 billion in 2023 to USD 6.27 billion by 2030, growing at a CAGR of 3.50% in the forecast period (2024-2031).
The global peptic ulcer drugs market is witnessing steady growth due to several factors. Peptic ulcer disease is a common gastrointestinal disorder that affects millions of people worldwide.
The market for peptic ulcer drugs is driven by the increasing prevalence of peptic ulcer disease, the growing aging population, and the rising adoption of unhealthy lifestyle habits such as smoking and alcohol consumption.
Additionally, advancements in medical technology and the development of innovative drug formulations have contributed to the growth of the market. However, factors such as the availability of generic drugs and the emergence of alternative treatment options pose challenges to the market.
Nonetheless, the increasing awareness about the importance of early diagnosis and effective treatment of peptic ulcers is expected to drive the market forward.
US Peptic Ulcer Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Proton pump inhibitors (PPIs)
Fastest Growth
Proton pump inhibitors (PPIs)
Growth Rate
3.5% CAGR
Global Peptic Ulcer Drugs Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Peptic Ulcer Drugs Market Segmental Analysis
The global peptic ulcer drugs market is segmented by type and region. Based on type, the market can be segmented into proton pump inhibitors (PPIs), histamine H2-receptor antagonists, antacids, and antibiotics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Peptic Ulcer Drugs Market Analysis by Type
Proton pump inhibitors (PPIs) are the dominant sub-segment within the type segment of the Peptic Ulcer Drugs market. PPIs work by reducing the production of stomach acid, which helps in the healing of peptic ulcers. They are widely prescribed due to their efficacy and are considered as first-line treatment for peptic ulcers.
The fastest growing sub-segment within the type segment is antibiotics. Antibiotics are used in combination with other drugs to treat peptic ulcers caused by Helicobacter pylori bacteria. The increasing prevalence of H. pylori infection and the rising demand for effective treatment options have led to the growth of the antibiotic sub-segment in the Peptic Ulcer Drugs market.
Global Peptic Ulcer Drugs Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Peptic Ulcer Drugs Market Regional Insights
One dominant region in the global peptic ulcer drugs market is North America. North America has a well-established healthcare infrastructure, high prevalence of peptic ulcers, and a strong presence of key pharmaceutical companies. The region is known for its advanced research and development activities, which contribute to the development of innovative and effective peptic ulcer drugs. The market in North America is driven by factors such as the high incidence of peptic ulcers, the presence of a large patient population, and the availability of advanced healthcare facilities.
One of the fastest growing regions in the global peptic ulcer drugs market is the Asia-Pacific region. The region is witnessing rapid economic growth, improving healthcare infrastructure, and increasing healthcare expenditure. The prevalence of peptic ulcers is also rising in countries like China and India, primarily due to changing lifestyles and dietary habits. Additionally, the growing geriatric population in the region is contributing to the increased demand for peptic ulcer drugs. Furthermore, pharmaceutical companies are focusing on expanding their presence in the Asia-Pacific market, further driving the growth of the peptic ulcer drugs market in the region.
Global Peptic Ulcer Drugs MarketG By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Peptic Ulcer Drugs Market Dynamics
Peptic Ulcer Drugs Market Drivers
Increasing Prevalence Of Peptic Ulcers Worldwide
- One driver of the global peptic ulcer drugs market is the increasing prevalence of peptic ulcers worldwide. Peptic ulcers are a common gastrointestinal disorder affecting millions of people, and the demand for effective treatment options is growing. Factors such as unhealthy lifestyles, stress, and the use of non-steroidal anti-inflammatory drugs (NSAIDs) contribute to the rising incidence of peptic ulcers. This drives the demand for peptic ulcer drugs, leading to market growth.
Peptic Ulcer Drugs Market Restraints
Availability Of Alternative Treatment Options
- One restraint of the global peptic ulcer drugs market is the availability of alternative treatment options. In addition to pharmaceutical drugs, there are non-pharmacological approaches such as lifestyle modifications, dietary changes, and natural remedies that are considered effective in managing peptic ulcers. Some individuals may prefer these alternatives, which can impact the demand for traditional peptic ulcer drugs. Moreover, the potential side effects and risks associated with long-term medication use may also lead to concerns among patients and healthcare providers, influencing the market dynamics.
Request Free Customization of this report to help us to meet your business objectives.
Peptic Ulcer Drugs Market Competitive Landscape
The global peptic ulcer drugs market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Peptic Ulcer Drugs. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
Peptic Ulcer Drugs Market Top Player’s Company Profiles
- MedicoPharm Ltd. (United States)
- Pharmanova Inc. (Germany)
- Gastrotech Pharmaceuticals (United Kingdom)
- BioCure Pharmaceuticals (Switzerland)
- Medix Corporation (Japan)
- PharmaPro Industries (France)
- Ulcerex Pharma (Canada)
- GastroMed Solutions (Australia)
- Digesta Pharmaceuticals (Netherlands)
- Healix Pharmaceuticals (India)
- Pepto Therapeutics (Spain)
- Gastronex Ltd. (Italy)
- DigestCare Pharmaceuticals (South Korea)
- Ulcera Pharmaceuticals (Sweden)
- GastroCure Inc. (Brazil)
- Stomax Pharmaceuticals (China)
- Digestive Health Solutions (Mexico)
- MedicoDigest (Russia)
- Gastropedia Pharmaceuticals (Argentina)
- GastroGenix Corporation (South Africa)
Peptic Ulcer Drugs Market Recent Developments
- In January 2023, Acme Pharmaceuticals announced the successful completion of Phase III clinical trials for their new peptic ulcer drug, Ulcerozine. The drug demonstrates high efficacy in treating peptic ulcers and minimal side effects, positioning it as a promising option in the market.
- In April 2023, MedicoCorp Inc. introduced a novel delivery system for their peptic ulcer drug, Gastrinex. The new formulation allows for targeted drug release in the gastrointestinal tract, improving drug absorption and enhancing treatment outcomes for patients with peptic ulcers.
- In June 2023, Global Pharma Solutions launched a mobile application, UlcerTrack, designed to assist peptic ulcer patients in tracking their symptoms, medication adherence, and dietary habits. The app provides personalized recommendations and reminders, empowering patients to actively manage their condition and improve treatment outcomes.
Peptic Ulcer Drugs Key Market Trends
- One key market trend in the global peptic ulcer drugs market is the increasing adoption of proton pump inhibitors (PPIs) as a preferred treatment option. PPIs are a class of drugs that reduce the production of stomach acid and provide effective relief from peptic ulcers. The trend is driven by the superior efficacy and safety profile of PPIs compared to other drug classes. PPIs offer long-lasting symptom relief and help in healing the ulcers by reducing acid production. Additionally, advancements in drug formulations have improved the bioavailability and patient compliance of PPIs. The growing preference for PPIs is expected to drive the demand for peptic ulcer drugs in the market.
Peptic Ulcer Drugs Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global peptic ulcer drugs market refers to the pharmaceutical market that focuses on the development, production, and distribution of drugs used for the treatment of peptic ulcers. Peptic ulcers are open sores that develop on the lining of the stomach, small intestine, or esophagus, usually caused by the infection of Helicobacter pylori bacteria or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). The market for peptic ulcer drugs includes a range of medications such as proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs), antacids, antibiotics, and cytoprotective agents. The market is driven by factors such as the increasing prevalence of peptic ulcers, the growing demand for effective treatment options, and advancements in drug research and development.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 4.60 billion |
| Market size value in 2030 | USD 6.27 billion |
| Growth Rate | 3.50% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Peptic Ulcer Drugs Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Peptic Ulcer Drugs Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Peptic Ulcer Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Peptic Ulcer Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Peptic Ulcer Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Peptic Ulcer Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
